Evidence map›Paper›PMID 37509272›Full record

ReviewCancers2023

Deep Learning for Medical Image-Based Cancer Diagnosis.

Xiaoyan Jiang, Zuojin Hu, Shuihua Wang, Yudong Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 4 pooled it
62.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 4 syntheses or guidelines pooled it, 272 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. LLM-powered prostate cancer staging from PSMA-PET/CT reports using PROMISE v2.European journal of nuclear medicine and molecular imaging · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Targeting extrachromosomal DNA in human cancers.Nature reviews. Drug discovery · 2026
    Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xiaoyan JiangSchool of Mathematics and Information Science, Nanjing Normal University of Special Education, Nanjing 210038, China.
Zuojin HuSchool of Mathematics and Information Science, Nanjing Normal University of Special Education, Nanjing 210038, China.
Shuihua WangSchool of Computing and Mathematical Sciences, University of Leicester, Leicester LE1 7RH, UK.
Yudong ZhangSchool of Computing and Mathematical Sciences, University of Leicester, Leicester LE1 7RH, UK.ORCID 0000-0002-4870-1493
Nanjing Normal University · CNUniversity of Leicester · GB

Funding

BBSRC RM32G0178B8BBSRC, UK RM32G0178B8BHF, UK AA/18/3/34220Data Science Enhancement Fund, UK P202RE237Fight for Sight, UK 24NN201GCRF, UK P202PF11Hope Foundation for Cancer Research, UK RM60G0680LIAS, UK P202ED10, P202RE969Major project of philosophy and social science research in colleges and universities in Jiangsu Province, China 2023SJZD125MRC, UK MC_PC_17171Royal Society, UK RP202G0230Sino-UK Education Fund, UK OP202006Sino-UK Industrial Fund, UK RP202G0289
6 · The paper itself

Abstract

(1) Background: The application of deep learning technology to realize cancer diagnosis based on medical images is one of the research hotspots in the field of artificial intelligence and computer vision. Due to the rapid development of deep learning methods, cancer diagnosis requires very high accuracy and timeliness as well as the inherent particularity and complexity of medical imaging. A comprehensive review of relevant studies is necessary to help readers better understand the current research status and ideas. (2) Methods: Five radiological images, including X-ray, ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), positron emission computed tomography (PET), and histopathological images, are reviewed in this paper. The basic architecture of deep learning and classical pretrained models are comprehensively reviewed. In particular, advanced neural networks emerging in recent years, including transfer learning, ensemble learning (EL), graph neural network, and vision transformer (ViT), are introduced. Five overfitting prevention methods are summarized: batch normalization, dropout, weight initialization, and data augmentation. The application of deep learning technology in medical image-based cancer analysis is sorted out. (3) Results: Deep learning has achieved great success in medical image-based cancer diagnosis, showing good results in image classification, image reconstruction, image detection, image segmentation, image registration, and image synthesis. However, the lack of high-quality labeled datasets limits the role of deep learning and faces challenges in rare cancer diagnosis, multi-modal image fusion, model explainability, and generalization. (4) Conclusions: There is a need for more public standard databases for cancer. The pre-training model based on deep neural networks has the potential to be improved, and special attention should be paid to the research of multimodal data fusion and supervised paradigm. Technologies such as ViT, ensemble learning, and few-shot learning will bring surprises to cancer diagnosis based on medical images.

Indexed as

artificial intelligencecancer diagnosisdeep learningdeep neural networkmedical imageoverfitting prevention technique

Identifiers

PMID37509272
PMCPMC10377683
OpenAlexW4384341111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.